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Chapter 6 
 
Investigations into the stabilization of drugs         
by sugar glasses: Tablets prepared from 
 stabilized alkaline phosphatase 
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Summary 
 
 The aim of this study was to investigate the formulation of sugar 
glass stabilized alkaline phosphatase from bovine intestine (BIAP) into 
tablets. Two major subjects of tablet formulation were investigated. First, 
the compaction behaviour of the inulin sugar glass was investigated. 
Secondly, the effect of the compaction process on the physical stability of 
sugar glass stabilized BIAP was evaluated, comparing inulin and trehalose 
glass. The tabletting properties of freeze-dried inulin without BIAP were 
studied first. Freeze-dried inulin conditioned at 20 °C/0% relative 
humidity (RH) or 20 °C/45% RH was compacted at various pressures. As 
expected, the yield pressure of the material conditioned at 0% RH was 
higher (68 MPa) than after conditioning at 45% RH (39 MPa). Tablets made 
of the material stored at 0% RH showed severe capping tendency, 
especially at high compaction pressures. In contrast, material conditioned 
at 45% RH gave tablets without any capping tendency and a friability of 
less than 1%.  
 Sugar glasses of BIAP and either inulin or trehalose were prepared by 
freeze-drying (BIAP/sugar 1/19 (w/w). The material was subsequently 
compacted. Tablets and powders were stored at 60 °C/0% RH. The activity 
of the incorporated BIAP was measured at various time intervals. It was 
found that inulin was by far superior to trehalose as stabilizer of BIAP in 
tablets. The poor stabilizing capacities of trehalose after compaction are 
explained by crystallization of trehalose induced by the compaction process 
and moisture in the material.  
 The results clearly show that inulin is an excellent stabilizer for BIAP. 
The tabletting properties are adequate, showing sufficient tablet strengths 
and low friability. Furthermore, the good (physical) stability of inulin glass 
with respect to exposure to high relative humidities makes it practical to 
work with. 
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6.1 Introduction 
 
 Pharmaceutically active proteins have been applied for decades. 
However, their number was small until the 1980s, but since that time rapid 
developments in molecular biology resulted in a fast increase. Currently, 
the FDA has approved over 30 different recombinant DNA-derived 
proteins, e.g. erythropoietin, interferon alpha-2a/b, somatropin, and 
follitropin beta and many more are already in a far stage of development. 
This fast growth calls for the development of dosage forms that provide 
stability of the drug during manufacturing and subsequent storage and 
that also allow patient friendly administration. 
 Stabilization of proteins can be achieved by mixing the protein 
solution with a sugar after which the solution is lyophilized or spray-dried. 
If dried properly, the protein is incorporated in a matrix consisting of 
amorphous sugar in its glassy state. Among other things, stabilization is 
achieved because the mobility of the protein is strongly reduced. Several 
review articles that cover this subject have been published [1-3]. It is often 
claimed that trehalose is superior as stabilizer when compared to other 
sugars, like sucrose, maltose, raffinose or lactose [4-11]. However, recently 
it was shown that also inulin provides excellent stabilization of proteins 
during freeze-drying and subsequent storage [12].  
 Once in the dry state, it is possible to develop other than liquid 
dosage forms, such as tablets or powders for inhalation. Although there is a 
substantial amount of papers dealing with the stabilization of proteins by 
lyophilization or spray-drying, papers on the formulation of these drugs 
for oral administration are scarce. Nonetheless, quite recently a paper on 
the stabilization of an antibiotic freeze-dried with trehalose and 
subsequently compacted was presented [11]. However, no experimental 
details were mentioned. In a previous study spray-dried inulin was tested 
as excipient for direct compaction [13]. It was shown that this material has 
excellent tabletting properties. In the study by Hinrichs et al. [12] the 
possibility to use inulin as a stabilizer of proteins was explored, while in 
the study by Eissens et al. [13] the compaction properties of spray-dried 
inulin without the presence of a protein were investigated. 
 The aim of this study was to investigate the formulation of sugar 
glass stabilized alkaline phosphatase from bovine intestine (BIAP) into 
tablets. Two major subjects of tablet formulation were investigated. First, 
the compaction behaviour of the inulin sugar glass was evaluated. 
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Secondly, the effect of the compaction process on the physical stability of 
sugar glass stabilized BIAP was investigated, comparing inulin and 
trehalose glasses. 
 Alkaline phosphatase (AP) is a thermolabile enzyme [14, 15] that 
currently is investigated within the University of Groningen as a potential 
treatment of sepsis, which is caused by endotoxins produced by Gram-
negative bacteria. In the case of sepsis the permeability across the intestinal 
wall increases, which might allow endotoxins to enter the blood stream. 
The AP can detoxify these endotoxins by removal of their phosphate 
groups. Since a local effect in the intestinal lumen is desired delivery of AP 
via the oral route is preferred. 
 
 
6.2 Material and methods 
 
Material  
 Inulin with a number/weight average degree of polymerization 
(DPn/DPw) of 23/26 was a gift from Sensus (Rosendaal, The Netherlands), 
D-(+)-trehalose and alkaline phosphatase from bovine intestine mucosa 
(BIAP) were purchased from Sigma (St Louis, MO, USA), para-
nitrophenylphosphate and 2-amino-2-methyl-1,3-propanediol were 
purchased from Sigma-Aldrich (Steinheim, Germany), and MgCl2 was from 
Fluka (Buchs, Switzerland). NaOH and HCl were purchased from Merck 
(Darmstadt, Germany).  
 
Freeze-drying 
 Solutions of inulin (10% w/v in demineralized water), BIAP/inulin, 
BIAP/trehalose (both 1/19 w/w, 10% w/v in 0.05 M ammediol (pH 9.8)) 
and BIAP without sugar (0.25% w/v in 0.05 M ammediol (pH 9.8)) were 
rapidly frozen in liquid nitrogen. Freeze-drying was carried out in a Christ 
Alpha 1-4 freeze-dryer (Salm en Kipp, Breukelen, The Netherlands) as 
follows; 96 hours at a shelf temperature of –35 °C, a condenser temperature 
of –53 °C, and a pressure of 0.220 mbar followed by a stepwise increase 
during 6 h to 20 °C and 0.520 mbar, which then was maintained for another 
20 hours. After freeze-drying, the samples were kept in a vacuum 
desiccator for at least four days. 
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Compaction behaviour of freeze-dried inulin 
 Before compaction freeze-dried inulin was gently ground and then 
equilibrated at either 20 °C/0% RH or 20 °C/45% RH. Tablets (round, flat, 
diameter 13 mm, weight 300 mg) were prepared with a compaction 
simulator (ESH, Brierley Hill, UK) at an average compaction speed of 
3 mm/s. In the compaction chamber the temperature was 19 °C and the 
relative humidity was 60%. The compaction pressures varied between 
7 and 210 MPa. Between each compaction the die was lubricated with 
magnesium stearate. The upper punch displacements were sine waves with 
different amplitudes in order to obtain different compaction pressures. The 
lower punch was stationary during compaction and the ejection time was 
always 10 s. The yield pressure of the inulin was calculated according to 
Heckel [16]. In short, the –ln (porosity under pressure) is plotted against the 
compaction pressure and then the equation of the linear region is 
calculated. The yield pressure is retrieved from the reciprocal of the slope. 
After ejection the tablets were stored for at least 16 h at 20 °C and a relative 
humidity as before compaction. To determine the porosity of the tablets 
after relaxation their dimensions were measured with an electronic 
micrometer (Mitutoyo, Tokyo, Japan) and the tablets were weighed on an 
analytical balance (Mettler-Toledo, Greifensee, Germany). The density of 
the tablets (DT) was calculated and then the porosity was calculated as 1-
DT/DI, where DI=the true density of inulin glass (1.480 g/cm3 for inulin at 
45% RH and 1.534 g/cm3 for inulin at 0% RH) [13]. The crushing strengths 
were measured with the compaction simulator as described previously [17, 
18].  
 The friability of tablets made from material conditioned at 
20 °C/45% RH was tested according to the European Pharmacopoeia [19]. 
 
Production of tablets for stability testing 
 Tablets for the stability testing of BIAP incorporated in inulin or 
trehalose glasses were produced using a hydraulic press (ESH, Brierley 
Hill, UK). The material containing inulin had been conditioned at 
20 °C/45% RH, while the material containing trehalose had been 
conditioned at 20 °C/0% RH in order to prevent crystallization. The RH in 
the room where compaction took place was 70% and the temperature was 
20 °C. The weighing of powders followed by compaction was performed as 
fast as possible (< 1 minute per tablet). A compaction pressure of 110 MPa 
was used for all the tablets. Immediately after compaction the tablets were 
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transferred to a vacuum desiccator. After 16 to 20 hours the enzymatic 
activity was measured. Tablets from each material were stored at 60 °C/0% 
RH or in the vacuum desiccator at room temperature. Uncompacted 
powders were stored similarly. The enzymatic activity of the BIAP was 
measured at different time intervals up to 3 months.  
 
Physical stability of freeze-dried trehalose and inulin 
 Trehalose and inulin were freeze-dried from aqueous solutions that 
contained 10% w/v of the respective sugars as described above. After 
freeze-drying the materials were stored at 0% RH in a vacuum desiccator 
for at least 2 days. Trehalose was then stored at 0, 33 and 45% RH, 
respectively, while inulin was stored at 0 and 45% RH, respectively, all at 
room temperature. The freeze-dried trehalose and inulin powders and 
tablets prepared from these powders were also stored at 60 °C/0% RH and 
60 °C/33% RH. The tablets were made after the materials had been stored 
for at least two weeks in their respective climates. The compaction process 
took place under a stream of dry nitrogen in order to achieve 0% RH and 
thus eliminate the influence of moisture present in the compaction 
chamber. The physical appearance of the powders was investigated before 
compaction. Furthermore, the thermal behaviour of the samples was 
evaluated in duplicate using differential scanning calorimetry (DSC) at a 
scanning rate of 20 °C/min in open aluminium pans using approximately 
10 mg for each measurement. The instrument, a TA Instruments DSC 2920 
(TA instruments, Ghent, Belgium), had been calibrated with indium and 
the instrument was also equipped with a cooling device that was supplied 
with a stream of nitrogen throughout the measurements.  
 
Enzymatic activity assay 
 Just before the enzymatic activity assay the tablets were gently 
crushed to smaller pieces in a mortar. From each sample duplicates were 
weighed and each duplicate was assayed twice, according to a previously 
published method [12]. For each analysis a calibration curve in the range 
0 to 40 µg/ml of BIAP was prepared from untreated BIAP, which was 
stored at –18 °C. All samples were dissolved and diluted in 0.05 M 
ammediol in water (pH 9.8) to yield a final concentration of BIAP of about 
25 µg/ml. The enzymatic activity of the samples was determined by 
measuring the conversion of pNPP to its yellow product para-nitrophenol. 
For the assay 900 µl of a mixture of 97.8% v/v of 0.05 M ammediol (pH 9.8) 
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with 2.2% v/v of 100 mM MgCl2 and 50 µl of sample were mixed with 50 µl 
10 mg/ml pNPP in demineralized water. Immediately after the addition of 
the pNPP-solution the reaction mixtures were vortex mixed and then 
placed in a water bath (P.M. Tamson N.V., The Netherlands) set to 37 °C 
for 30 min. The reaction was quenched by adding 5.00 ml 0.1 M NaOH to 
the reaction solution. The absorbance at 405 nm of the samples was then 
measured using a Philips PU 8720 spectrophotometer (Philips, The 
Netherlands).  
 
 
6.3 Results and Discussion 
 
Compaction behaviour and tablet properties of freeze-dried inulin 
 The compaction behaviour of freeze-dried inulin was studied using 
the powders conditioned at 20 °C/0% RH and 20 °C/45% RH. The dry 
material showed capping tendency at compaction pressures higher than 
67 MPa. When the tablets were ejected from the die, this capping process 
was evident within a few seconds as an increase in tablet height was clearly 
visible and the tablets split. This behaviour is explained by the storage of 
elastic energy, which was released as a fracture in the tablet when the 
pressure was removed. In contrast, tablets made from the material stored at 
45% RH showed no capping, and tablets with high tensile strengths could 
be prepared. This behaviour has also been found for amorphous lactose 
[20]. In Fig. 1 the densification of both powders are shown as the porosity 
under pressure. The porosity under pressure was higher for the dry 
material compared to the moist material showing a difference in 
densification behaviour of the powders.  
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Fig. 1 The porosity under pressure versus compaction pressure for freeze-dried inulin conditioned at 
20 °C/0% RH (○) and 20 °C/45% RH (●), respectively. 
 
The yield pressure, which is regarded as a measure of the densification of 
powder was calculated from the Heckel-plots (Fig. 2) using the linear range 
between 11 and 110 MPa (r2=0.992) for the tablets from 0% RH, and 7 to 
120 MPa (r2=0.996) for the tablets made from 45% RH. The yield pressures 
of inulin conditioned at 0% RH and 45% RH were found to be 68 MPa and 
39 MPa, respectively. The decreased yield pressure with increased 
humidity can be ascribed to the plasticizing effect of water, which facilitates 
deformation. Similar results have also been found for amorphous lactose 
[21] and amylodextrins [22]. In Fig. 3 the tensile strength as a function of 
compaction pressure is shown. The tablets made from material stored at 
45% RH show a good linear behaviour up to 130 MPa, while tablets made 
from material stored at 0% RH demonstrate a more scattered behaviour, 
which can be explained by the capping behaviour mentioned above. At 
compaction pressures above 90 MPa the tensile strength of the tablets made 
from the material equilibrated at 45% RH decreased.  
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Fig. 2 The –ln (porosity under pressure) versus compaction pressure for freeze-dried inulin conditioned at 
20 °C/0% RH (○) and 20 °C/45% RH (●), respectively. 
 
Most likely, at these high pressures material densification with concomitant 
elastic energy storage occurred, resulting in internal non-visible capping. 
The reason for the increased tensile strength of tablets prepared from the 
moist material can again be found in the ability of absorbed water to act as 
a plasticizer. As a result, the degree of plastic deformation increases during 
compaction, and the lower porosity leads to a closer packing of the 
particles. This means that the available bonding surface within the tablet 
increases [23].  
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Fig. 3 The tensile strength as function of compaction pressure for freeze-dried inulin conditioned at 20 °C/0% RH 
(○) and 20 °C/45% RH (●), respectively. 
 
 Because inulin conditioned at 20 °C/0% RH had poor compaction 
behaviour, tablets for the stability tests were compacted of inulin 
conditioned at 20 °C/45% RH. After 100 turns in the friabilator all tablets 
made from freeze-dried inulin compacted at 110 MPa were still intact. The 
friability of the tablets conditioned at 20 °C/45% RH was found to be 0.6%, 
which is within the requirements of the European Pharmacopoeia [19].  
 
Stability of alkaline phosphatase 
 In a previous study [12] it was found that trehalose provided no 
protection of BIAP when stored at 60 °C/0% RH for six days, but when 
inulins were used the remaining activity was about 55%. However, in that 
study the ratio between BIAP/trehalose was 1/9 w/w, while in the present 
study the ratio was 1/19 w/w. The stability of BIAP incorporated in sugar 
glasses of either inulin or trehalose was tested by exposing powders and 
tablets to 60 °C/0% RH. For comparison, uncompacted powders and 
tablets were also stored at 20 °C/0% RH. Tablets containing inulin were 
made from material conditioned at 20 °C/45% RH. The tablets containing 
trehalose were made from material conditioned at 20 °C/0% RH, because 
amorphous trehalose easily passes the glass transition temperature upon 
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exposure to humidified air [7]. Crystallization will be detrimental to the 
incorporated BIAP, since the protection will be completely lost. 
 The enzymatic activity of BIAP after freeze-drying and the 
subsequent process steps was fully maintained in all cases where trehalose 
or inulin glasses were used (Table I) as protectant. When no protectant was 
used the activity of BIAP was almost completely lost after freeze-drying, 
indicating that both trehalose and inulin are excellent stabilizers during 
drying. 
 
Table I. Remaining relative activity of BIAP after various process steps. Given is the enzymatic activity relative  
to theoretical values. 
Sugar Freeze-drying 
(%) 
Grinding 
(%) 
Pre-conditioning 
(%) 
Compaction 
(%) 
Inulin 108.9±0.4 110.3±0.3 103.8±1.1 99.5±2.8 
Trehalose 107.5±3.5 101.1±2.3 102.8±2.3 99.9±0.8 
No Protectant 5.4±2.1 n.a. n.a. n.a. 
 
 The appearance of the tablets made from inulin was different from 
the trehalose tablets. The surface of the trehalose tablets was not as smooth 
and they were very sticky. To minimize the moisture uptake the 
compaction was performed as rapidly as possible (less than a minute 
between weighing the material and compaction). However, during this 
procedure the freeze-dried amorphous trehalose material probably 
absorbed some water, which might cause a suppression of the Tg [24, 25].  
 In Fig. 4 the results of the stability test are given. Already after 3 days 
at 60 °C the activity in tablets prepared from trehalose had dropped to 
20.3±4.6% of the original value. Moreover, after 8 days storage at 60 °C the 
tablets made from trehalose had turned a little yellow and they also had a 
foul smell. On the other hand, the tablets were less sticky than immediately 
after compaction. In addition, the enzymatic activity of the BIAP 
completely disappeared. This is in sharp contrast to the trehalose powder, 
which shows a good stability. On the other hand, the BIAP in the tablets 
made from inulin showed about the same stability as the powder (75±3% 
activity after 3 months at 60 °C/0% RH).  
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Fig. 4 The remaining enzymatic activity of sugar-incorporated BIAP (compacted and non-compacted) after 
storage at 60 °C. Inulin tablet (●), Trehalose tablet (○), Inulin powder (), Trehalose powder (□). 
 
When the stability of both powders was compared the BIAP was somewhat 
more stable when it was incorporated in trehalose. The enzymatic activity 
of BIAP for the samples stored at 20 °C/0% RH showed no loss of activity 
during the test period (Table II), indicating that both trehalose and inulin 
are excellent stabilizers when stored at mild conditions such as 20 °C/0% 
RH.    
 
Table II. Remaining activity of BIAP after storage of powders at 20 °C/0% RH. 
Days Inulin/BIAP 
(%) 
Trehalose/BIAP 
(%) 
0 99.8±1.9 107.5±1.9 
28 97.2±2.1 100.6±0.5 
57 99.8±1.2 101.1±1.4 
105 95.3±1.1 105.4±3.1 
 
Physical stability of trehalose and inulin glasses 
 BIAP incorporated in trehalose completely loses its activity within 
eight days after compaction and storage at 60 °C. The fast disintegration of 
tablets containing BIAP incorporated in trehalose may be explained by the 
crystallization behaviour of trehalose. Factors such as moisture and 
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compaction may induce crystallization of amorphous sugars. As mentioned 
above, amorphous BIAP/trehalose became very sticky during the 
compaction process. Therefore, it is likely that the glass had partially 
turned into a rubber due to the compaction process and/or moisture 
uptake, i.e. the Tg had dropped to close to room temperature. As a result, 
the low Tg in combination with the compaction process and subsequent 
storage at 60 °C, crystallization of the lyophilized trehalose and 
consequently loss of protection of BIAP occured. 
 This hypothesis is endorsed by the result of the DSC analysis 
showing an endothermic peak at 213 °C (Fig. 5), indicating that the material 
had fully turned into crystalline anhydrous trehalose [26]. The 
uncompacted trehalose, on the other hand, did not show any melting at 
213 °C, while a Tg at 108 °C was observed indicating the existence of 
amorphous material (Fig. 5). 
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Fig. 5 DSC of freeze-dried trehalose/BIAP immediately after compaction (a) and after compaction and storage at 
60 °C/0% RH (b), respectively. 
 
Pure amorphous trehalose has previously been reported to have a Tg of 
115 °C [27] and 119 °C [26], respectively. The somewhat lower Tg found 
here can be ascribed to the presence of BIAP and/or buffer components in 
the sample.  
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 Crystallization caused by compaction was not observed for the 
freeze-dried inulin that had been stored at 45% RH before compaction. 
Obviously, inulin does not seem to crystallize as easily as trehalose, since 
the Tg was still clearly detectable at 151 °C (Fig. 6).  
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Fig. 6 DSC of amorphous inulin (a) and crystalline inulin (b).  
 
Crystalline inulin was also measured by DSC and the result is shown in 
Fig. 6. As can be seen no Tg is measured but only a melting peak at 182 °C. 
In a previous study it has also been shown that amorphous inulin can 
absorb much higher amounts of water, compared to amorphous trehalose, 
without showing crystallization at room temperature [12]. 
 This was further investigated by freeze-drying trehalose and inulin 
and compaction of powders, followed by storing the powders and 
compacts under various conditions. In Table III the results of the 
investigation of trehalose are given. As can be seen, freeze-dried trehalose 
remains amorphous when stored under dry conditions. 
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Table III. Compilation of DSC data of trehalose. aWhen exposed to humidified air, the Tg will decrease due to the 
uptake of water. However, DSC was performed in open pans. As a result, absorbed water will evaporate during the 
measurement and a Tg of the dry material is measured. 
Preconditioning DSC Conditioning after compaction DSC 
RH (%) T (°C) Tg (°C) Tm (°C) RH (%) T (°C) Tg (°C) Tm (°C) 
0 20 123 - 0 20 122 - 
0 60 122 - 0 60 123 - 
33 20 122a - 33 20 - 104/210 
33 60 - 215 n.a. n.a. - - 
45 20 - 108 n.a. n.a. - - 
 
For these samples only a Tg at ca 122 °C was found (see also Fig 7). This Tg 
is in good agreement with what others have found for amorphous trehalose 
[26]. When the freeze-dried trehalose was stored at 20 °C/33% RH it still 
remained amorphous, but when this material was compacted it crystallized 
as both trehalose dihydrate and trehalose anhydrate, which could be 
concluded from melting peaks at 104 °C and 210 °C, respectively (see also 
Fig. 7). If the freeze-dried trehalose was conditioned at 20 °C/33% RH and 
then compacted and stored at 60 °C/33% RH it crystallized as trehalose 
anhydrate. For this material no Tg was seen, but only a melting signal at 
215 °C was detected in the DSC measurement (see also Fig. 7).  After 
storage at 20 °C/45% RH the freeze-dried trehalose powder turned into a 
hard cake, and when subjected to DSC melting of trehalose dihydrate was 
detected at 108 °C (see also Fig. 7). 
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Fig. 7 DSC of freeze-dried trehalose stored at 20 °C/0% RH (a), freeze-dried trehalose stored at 20 °C/45% RH 
(b), freeze-dried trehalose stored at 20 °C/33% RH followed by compaction and storage at 20 °C/33% RH 
(c),compacted freeze-dried trehalose stored at 60 °C/33% RH (d), respectively. 
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When all these results are taken together it is evident that moisture and 
elevated temperature facilitates crystallization of amorphous trehalose. 
Moreover, crystallization is also induced when the powders are compacted. 
In previous studies of the crystallization behaviour of trehalose it was 
found that amorphous trehalose that was humidified at RHs below 44% 
would not crystallize due to lack of water [7, 8]. However, if the amorphous 
trehalose was exposed to RHs above 44% it rapidly crystallized. The 
crystallization of trehalose has previously been claimed to be the reason for 
the loss of protection of lactase [8]. The results that were found in our 
investigation of the crystallization behaviour of amorphous trehalose in 
combination with the findings of others support our assumption that 
crystallization of trehalose indeed was the reason for the loss of protection 
and subsequent degradation of the BIAP during the stability study. 
 For inulin it was found that it remained amorphous in climates up to 
45% RH, and no collapse of the material was visible. Even when inulin was 
stored at 60 °C/33% RH it did not crystallize, not even after compaction. 
These results clearly show that inulin has a lower tendency to crystallize 
than trehalose, which further explains why the alkaline phosphatase was 
more stable when freeze-dried with inulin than with trehalose. It is evident 
that in order to achieve a good stabilization of a protein the use of inulin as 
stabilizer is to prefer above trehalose. 
 
 
6.4 Conclusions 
 
 Tablets with adequate tensile strengths and low friability can be 
made of amorphous inulin. The moisture content in the material affected 
the compaction properties of inulin. In addition, the results indicate that 
tablets can be made of proteins incorporated in the inulin glass without loss 
of activity during compaction and subsequent storage, which is not the case 
for trehalose.  
 Our assumption that crystallization of trehalose was the reason for 
the lost activity of BIAP was also confirmed. Indeed, it was found that 
amorphous trehalose started crystallizing when exposed to various process 
conditions, such as increased RH, increased temperature and compaction, a 
phenomenon that was not found for amorphous inulin. These findings 
point to the superiority as stabilizer of amorphous inulin over amorphous 
trehalose. Inulin can be processed under less tight conditions, i.e. 
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amorphous inulin can be exposed to higher RHs than amorphous trehalose, 
which readily crystallizes. Inulin is clearly a better choice than trehalose 
when solid dosage forms are prepared. 
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